247 related articles for article (PubMed ID: 15180022)
61. The relation of patient satisfaction with treatment of otitis externa to clinical outcomes: development of an instrument.
Shikiar R; Halpern MT; McGann M; Palmer CS; Seidlin M
Clin Ther; 1999 Jun; 21(6):1091-104. PubMed ID: 10440629
[TBL] [Abstract][Full Text] [Related]
62. Topical treatment of acute otitis externa: clinical comparison of an antibiotics ointment alone or in combination with hydrocortisone acetate.
Mösges R; Domröse CM; Löffler J
Eur Arch Otorhinolaryngol; 2007 Sep; 264(9):1087-94. PubMed ID: 17503066
[TBL] [Abstract][Full Text] [Related]
63. OTITIS IN SOUTHERN CALIFORNIA: PREVAILING BACTERIAL AGENTS OF INFECTION AND TREATMENT WITH A NEW THERAPEUTIC FORMULATION.
FRANKEL GW
West Med Med J West; 1964 Feb; 5():52-6. PubMed ID: 14119141
[No Abstract] [Full Text] [Related]
64. Comparative evaluation of the short-term bactericidal potential of a steroid-antibiotic combination versus steroid in the treatment of chronic bacterial blepharitis and conjunctivitis.
Shulman DG; Sargent JB; Stewart RH; Mester U
Eur J Ophthalmol; 1996; 6(4):361-7. PubMed ID: 8997575
[TBL] [Abstract][Full Text] [Related]
65. Antimicrobial effect of combinations of EDTA-Tris and amikacin or neomycin on the microorganisms associated with otitis externa in dogs.
Sparks TA; Kemp DT; Wooley RE; Gibbs PS
Vet Res Commun; 1994; 18(4):241-9. PubMed ID: 7831753
[TBL] [Abstract][Full Text] [Related]
66. A group III steroid solution without antibiotic components: an effective cure for external otitis.
Emgård P; Hellström S
J Laryngol Otol; 2005 May; 119(5):342-7. PubMed ID: 15949095
[TBL] [Abstract][Full Text] [Related]
67. In vitro antimicrobial activity of topical otological antimicrobials and Tris-EDTA against resistant Staphylococcus pseudintermedius and Pseudomonas aeruginosa isolates from dogs.
Boyd M; Santoro D; Gram D
Vet Dermatol; 2019 Apr; 30(2):139-e40. PubMed ID: 30672043
[TBL] [Abstract][Full Text] [Related]
68. Evaluation of biofilm production by Pseudomonas aeruginosa from canine ears and the impact of biofilm on antimicrobial susceptibility in vitro.
Pye CC; Yu AA; Weese JS
Vet Dermatol; 2013 Aug; 24(4):446-9, e98-9. PubMed ID: 23738965
[TBL] [Abstract][Full Text] [Related]
69. Endoscopic photographic comparison of drug delivery by ear-drops and by aerosol spray.
McGarry GW; Swan IR
Clin Otolaryngol Allied Sci; 1992 Aug; 17(4):359-60. PubMed ID: 1526058
[TBL] [Abstract][Full Text] [Related]
70. Comparison of microbial isolates and susceptibility patterns from the external ear canal of dogs with otitis externa.
Graham-Mize CA; Rosser EJ
J Am Anim Hosp Assoc; 2004; 40(2):102-8. PubMed ID: 15007044
[TBL] [Abstract][Full Text] [Related]
71. In vitro and in vivo antimicrobial activity of topical ofloxacin and other ototopical agents.
Klein JO
Pediatr Infect Dis J; 2001 Jan; 20(1):102-3; discussion 120-2. PubMed ID: 11176586
[TBL] [Abstract][Full Text] [Related]
72. Otitis externa infection in Jordan. Clinical and microbiological features.
Battikhi MN; Ammar SI
Saudi Med J; 2004 Sep; 25(9):1199-203. PubMed ID: 15448765
[TBL] [Abstract][Full Text] [Related]
73. Carriage of
Lee GY; Lee HH; Hwang SY; Hong J; Lyoo KS; Yang SJ
J Vet Sci; 2019 Mar; 20(2):e6. PubMed ID: 30944529
[TBL] [Abstract][Full Text] [Related]
74. In vitro antimicrobial activity of seven adjuvants against common pathogens associated with canine otitis externa.
Chan WY; Khazandi M; Hickey EE; Page SW; Trott DJ; Hill PB
Vet Dermatol; 2019 Apr; 30(2):133-e38. PubMed ID: 30548715
[TBL] [Abstract][Full Text] [Related]
75. Use of Cortisporin Otic Solution in phenol nail surgery.
Anton-Athens V; Ketai DL
J Am Podiatr Med Assoc; 1985 Jan; 75(1):31-3. PubMed ID: 2984406
[No Abstract] [Full Text] [Related]
76. EXTERNAL OTITIS. REPORT OF THE EFFECTIVENESS OF A NEW TOPICAL PREPARATION.
JONES EH; MCLAIN PG
Eye Ear Nose Throat Mon; 1964 Jul; 43():52-7. PubMed ID: 14176155
[No Abstract] [Full Text] [Related]
77. Treatment of otitis externa with miconazole nitrate. A comparative study involving 85 cases.
Bak JP; Wagenfeld DJ
S Afr Med J; 1983 Apr; 63(15):562-3. PubMed ID: 6342163
[TBL] [Abstract][Full Text] [Related]
78. Interventions for acute otitis externa.
Kaushik V; Malik T; Saeed SR
Cochrane Database Syst Rev; 2010 Jan; (1):CD004740. PubMed ID: 20091565
[TBL] [Abstract][Full Text] [Related]
79. Oral ofloxacin as treatment of malignant external otitis: a study of 17 cases.
Levy R; Shpitzer T; Shvero J; Pitlik SD
Laryngoscope; 1990 May; 100(5):548-51. PubMed ID: 2109817
[TBL] [Abstract][Full Text] [Related]
80. Pitfalls of polymyxin antimicrobial susceptibility testing of Pseudomonas aeruginosa isolated from cystic fibrosis patients.
Hogardt M; Schmoldt S; Götzfried M; Adler K; Heesemann J
J Antimicrob Chemother; 2004 Dec; 54(6):1057-61. PubMed ID: 15509615
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
